Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine.
Chanias I, Stojkov K, Stehle GT, Daskalakis M, Simeunovic H, Njue LM, Schnegg-Kaufmann AS, Porret NA, Allam R, Rao TN, Benz R, Ruefer A, Schmidt A, Adler M, Rovo A, Balabanov S, Stuessi G, Bacher U, Bonadies N, On Behalf Of The Swiss Mds Study Group. Chanias I, et al. Among authors: daskalakis m. Cancers (Basel). 2021 Jun 30;13(13):3296. doi: 10.3390/cancers13133296. Cancers (Basel). 2021. PMID: 34209457 Free PMC article. Review.
Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party.
Penack O, Peczynski C, Koenecke C, Polge E, Sanderson R, Yakoub-Agha I, Fegueux N, Daskalakis M, Collin M, Dreger P, Kröger N, Schanz U, Bloor A, Ganser A, Besley C, Wulf GG, Novak U, Moiseev I, Schoemans H, Basak GW, Chabannon C, Sureda A, Glass B, Peric Z. Penack O, et al. Among authors: daskalakis m. Front Immunol. 2023 Sep 27;14:1252811. doi: 10.3389/fimmu.2023.1252811. eCollection 2023. Front Immunol. 2023. PMID: 37828980 Free PMC article.
A high Gas6 level in plasma predicts venous thromboembolism recurrence, major bleeding and mortality in the elderly: a prospective multicenter cohort study.
Schnegg-Kaufmann A, Calzavarini S, Limacher A, Mean M, Righini M, Staub D, Beer JH, Frauchiger B, Osterwalder J, Kucher N, Matter CM, Husmann M, Banyai M, Aschwanden M, Mazzolai L, Hugli O, Nagler M, Daskalakis M, Rodondi N, Aujesky D, Angelillo-Scherrer A. Schnegg-Kaufmann A, et al. Among authors: daskalakis m. J Thromb Haemost. 2019 Feb;17(2):306-318. doi: 10.1111/jth.14365. J Thromb Haemost. 2019. PMID: 30570809 Free PMC article.
Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: A comparison between Swiss and American population-based cancer registries.
Benzarti S, Daskalakis M, Feller A, Bacher VU, Schnegg-Kaufmann A, Rüfer A, Holbro A, Schmidt A, Benz R, Solenthaler M, Stussi G, Arndt V, Bonadies N; NICER Working Group. Benzarti S, et al. Among authors: daskalakis m. Cancer Epidemiol. 2019 Apr;59:51-57. doi: 10.1016/j.canep.2019.01.003. Epub 2019 Jan 25. Cancer Epidemiol. 2019. PMID: 30690330
Chimeric antigen receptor T-cell therapy for relapsed mantle cell lymphoma: real-world experience from a single tertiary care center.
Heini AD, Bacher U, Kronig MN, Wiedemann G, Novak U, Zeerleder S, Mansouri Taleghani B, Daskalakis M, Pabst T. Heini AD, et al. Among authors: daskalakis m. Bone Marrow Transplant. 2022 Jun;57(6):1010-1012. doi: 10.1038/s41409-022-01658-x. Epub 2022 Apr 5. Bone Marrow Transplant. 2022. PMID: 35383289 No abstract available.
Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial.
Farag S, Bacher U, Jeker B, Legros M, Rhyner G, Lüthi JM, Schardt J, Zander T, Daskalakis M, Mansouri B, Manz C, Pabst T. Farag S, et al. Among authors: daskalakis m. Bone Marrow Transplant. 2022 Jun;57(6):990-997. doi: 10.1038/s41409-022-01681-y. Epub 2022 Apr 20. Bone Marrow Transplant. 2022. PMID: 35444232 Free PMC article. Clinical Trial.
115 results